Forexample, a man diagnosed with advanced prostate cancer may receive palliativetreatment with a dose of Anti-Androgens (AA, event 1), or Gonadotropin-releasinghormone (GnRH, event 2), and may die because of prostate cancer (event 3), or othercauses (event 4). The gene discussed is GNRH1; the disease is prostate carcinoma.